It is administered directly into the lungs of premature infants to treat or prevent Neonatal Respiratory Distress Syndrome.

Its purpose is to improve lung expansion and gas exchange by stabilizing alveoli and preventing their collapse.

Colfosceril Palmitate is a synthetic phospholipid that mimics natural lung surfactant to reduce surface tension in the alveoli.